Sionna Therapeutics, Inc. · NASDAQ:SION

Atlas Venture Fund XI, L.P. reported a 6.50% stake in Sionna Therapeutics, Inc. (Schedule 13D)

Event Feb 10, 2025 · Filed Feb 18, 2025

Atlas Venture Fund XI, L.P. reported a 6.50% stake in Sionna Therapeutics, Inc., 2,886,293 shares, with active intent on Feb 10, 2025. Filed Feb 18, 2025 (Schedule 13D).

Stake
6.50%
Shares
2,886,293
Intent
Active
What changed
Crossed above 5%
Filed together
6 holders

The filing in full

HolderStakeShares
Atlas Venture Fund XI, L.P.6.50%2,886,293
Atlas Venture Associates XI, L.P.6.50%2,886,293
Atlas Venture Associates XI, LLC6.50%2,886,293
Atlas Venture Opportunity Fund II, L.P.1.80%807,727
Atlas Venture Associates Opportunity II, LP1.80%807,727
Atlas Venture Associates Opportunity II, LLC1.80%807,727

Source

View original at SEC

Related